Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

VIVO BIO TECH LTD. - 511509 - Board Meeting Intimation for Board Meeting Intimation For Date Of The Board Meeting To Consider And Approve The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended 30Th June, 2022.

 VIVO BIO TECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2022 ,inter alia, to consider and approve The Company informs that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 10th August, 2022 at the Corporate Office of the Company to consider and approve the Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter ended 30th June, 2022.
27-07-2022
Bigul

VIVO BIO TECH LTD. - 511509 - Statement Of Deviation Or Variation In Utilization Of Funds Raised Through Preferential Issue For The Quarter Ended 30 June, 2022

 The Company has submitted with the exchange the Statement of Deviation or Variation in utilization of funds raised through preferential issue for the quarter ended 30 June, 2022.
19-07-2022
Bigul

VIVO BIO TECH LTD. - 511509 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 The Company has submitted with the exchange the Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the period from 1st April, 2022 to 30th June, 2022
12-07-2022
Bigul

VIVO BIO TECH LTD. - 511509 - Statement Of Investor Complaints For The Quarter Ended June 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Jyotika AasatDesignation :- Company Secretary and Compliance Officer
12-07-2022
Bigul

VIVO BIO TECH LTD. - 511509 - Closure of Trading Window

 This is to inform you that, pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 and Company's Internal Code of Conduct to Regulate, Monitor and Report Trading by Directors, Promoters and Designated Persons of the Company, the Trading Window for dealing in the securities of the Company shall remain Closed for all insiders including Designated Persons and their immediate relatives from Friday, July 01, 2022 till the end of 48 hours after the declaration of the un-audited financial results of the Company for the quarter ended 30th June, 2022.
30-06-2022
Bigul

VIVO BIO TECH LTD. - 511509 - Related Party Transaction For The Half-Year Ended 31.03.2022

 Please find enclosed the Disclosure under Related Party Transactions for the half year ended 31.03.2022 under Regulation 23 (9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
15-06-2022
Bigul

VIVO BIO TECH LTD. - 511509 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper Publication for Audited Financial Results for 31st March, 2022
01-06-2022
Bigul

Annual report for Vivo Bio Tech Ltd. for FY-2022
31-05-2022
Bigul

VIVO BIO TECH LTD. - 511509 - Audited Financial Results For The Fourth Quarter And Year Ended March 31, 2022

 The Company has submitted the Audited Financial Results for the fourth quarter and year ended March 31, 2022
30-05-2022
Bigul

VIVO BIO TECH LTD. - 511509 - Board Meeting Outcome for Outcome Of Board Meeting

 The Board of Directors of the Company at their meeting held today, viz. Monday, 30th May, 2022, interalia transacted the following business: 1. Approved Audited Standalone & Consolidated Financial Results for the fourth quarter and year ended 31st March, 2022. 2. Took note of the Auditor''s Reports forming part of Audited Standatone and Consolidated Financial Results for the fourth quarter and year ended 31''t March, 2022.
30-05-2022
Next Page
Close

Let's Open Free Demat Account